5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
| Field | Value | Language |
| dc.contributor.author | Cardoso, F. | en_AU |
| dc.contributor.author | Paluch-Shimon, S. | en_AU |
| dc.contributor.author | Senkus, E. | en_AU |
| dc.contributor.author | Curigliano, G. | en_AU |
| dc.contributor.author | Aapro, M.S. | en_AU |
| dc.contributor.author | André, F. | en_AU |
| dc.contributor.author | Barrios, C.H. | en_AU |
| dc.contributor.author | Bergh, J. | en_AU |
| dc.contributor.author | Bhattacharyya, G.S. | en_AU |
| dc.contributor.author | Biganzoli, L. | en_AU |
| dc.contributor.author | Boyle, F. | en_AU |
| dc.contributor.author | Cardoso, M.-J. | en_AU |
| dc.contributor.author | Carey, L.A. | en_AU |
| dc.contributor.author | Cortés, J. | en_AU |
| dc.contributor.author | Saghir, N.S. El | en_AU |
| dc.contributor.author | Elzayat, M. | en_AU |
| dc.contributor.author | Eniu, A. | en_AU |
| dc.contributor.author | Fallowfield, L. | en_AU |
| dc.contributor.author | Francis, P.A. | en_AU |
| dc.contributor.author | Gelmon, K. | en_AU |
| dc.contributor.author | Gligorov, J. | en_AU |
| dc.contributor.author | Haidinger, R. | en_AU |
| dc.contributor.author | Harbeck, N. | en_AU |
| dc.contributor.author | Hu, X. | en_AU |
| dc.contributor.author | Kaufman, B. | en_AU |
| dc.contributor.author | Kaur, R. | en_AU |
| dc.contributor.author | Kiely, B.E. | en_AU |
| dc.contributor.author | Kim, S.B. | en_AU |
| dc.contributor.author | Lin, N.U. | en_AU |
| dc.contributor.author | Mertz, S.A. | en_AU |
| dc.contributor.author | Neciosup, S. | en_AU |
| dc.contributor.author | Offersen, B.V. | en_AU |
| dc.contributor.author | Ohno, S. | en_AU |
| dc.contributor.author | Pagani, O. | en_AU |
| dc.contributor.author | Prat, A. | en_AU |
| dc.contributor.author | Penault-Llorca, F. | en_AU |
| dc.contributor.author | Rugo, H.S. | en_AU |
| dc.contributor.author | Sledge, G.W. | en_AU |
| dc.contributor.author | Thomssen, C. | en_AU |
| dc.contributor.author | Vorobiof, D.A. | en_AU |
| dc.contributor.author | Wiseman, T. | en_AU |
| dc.contributor.author | Xu, B. | en_AU |
| dc.contributor.author | Norton, L. | en_AU |
| dc.contributor.author | Costa, A. | en_AU |
| dc.contributor.author | Winer, E.P. | en_AU |
| dc.date.accessioned | 2020-12-21 | |
| dc.date.available | 2020-12-21 | |
| dc.date.issued | 2020 | en_AU |
| dc.identifier.uri | https://hdl.handle.net/2123/24193 | |
| dc.description.abstract | Highlights: This ESO-ESMO ABC 5 Clinical Practice Guideline provides key recommendations for managing advanced breast cancer patients. It provides updates on the management of patients with all breast cancer subtypes, LABC, follow-up, palliative and supportive care. Updated diagnostic and treatment algorithms are also provided. All recommendations were compiled by a multidisciplinary group of international experts. Recommendations are based on available clinical evidence and the collective expert opinion of the authors. | en_AU |
| dc.language.iso | en | en_AU |
| dc.subject | COVID-19 | en_AU |
| dc.subject | Coronavirus | en_AU |
| dc.title | 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) | en_AU |
| dc.type | Article | en_AU |
| dc.identifier.doi | 10.1016/j.annonc.2020.09.010 |
Associated file/s
There are no files associated with this item.
Associated collections